Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination

BACKGROUND: Paediatric patients with autoimmune rheumatic diseases (pARD) are often immunocompromised because of the disease and/or the therapy they receive. At the beginning of COVID-19 pandemic there was a great concern about the possibility of severe SARS-CoV-2 infection in these patients. The be...

Descripción completa

Detalles Bibliográficos
Autores principales: Šinkovec Savšek, Tjaša, Zajc Avramovič, Mojca, Avčin, Tadej, Korva, Miša, Avšič Županc, Tatjana, Toplak, Nataša
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197037/
https://www.ncbi.nlm.nih.gov/pubmed/37208721
http://dx.doi.org/10.1186/s12969-023-00829-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197037/
https://www.ncbi.nlm.nih.gov/pubmed/37208721
http://dx.doi.org/10.1186/s12969-023-00829-4

Ejemplares similares